Karyopharm Therapeutics Overview

Karyopharm Therapeutics Gross Profit

Gross Profit analysis for KPTI.

Quarterly Gross Profit

$33.71M

↑ 17.4% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$145.11M

↑ 13.93% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin